4.5 Editorial Material

Nrf2 as a therapeutic target in ischemic stroke

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Activation of Nrf2 by Natural Bioactive Compounds: A Promising Approach for Stroke?

Agnese Gugliandolo et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Pharmacology & Pharmacy

Critical Role of Nrf2 in Experimental Ischemic Stroke

Lei Liu et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Chemistry, Medicinal

Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates

Scott A. Reisman et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2019)

Article Clinical Neurology

Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia

David R. Lynch et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Article Mathematical & Computational Biology

Liraglutide Activates the Nrf2/HO-1 Antioxidant Pathway and Protects Brain Nerve Cells against Cerebral Ischemia in Diabetic Rats

Caihong Deng et al.

COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE (2018)

Review Neurosciences

Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke

Rongrong Zhang et al.

MOLECULAR NEUROBIOLOGY (2017)

Article Cell Biology

Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes

Annika S. Axelsson et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Review Biochemistry & Molecular Biology

Nrf2 signaling pathway: Pivotal roles in inflammation

Syed Minhaj Uddin Ahmed et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)

Review Biochemistry & Molecular Biology

The complexity of the Nrf2 pathway: beyond the antioxidant response

Ying Huang et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)